This page lists the SEC filings reported by Baker Brothers Advisors.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | HERON THERAPEUTICS, INC. /DE/ | 8,064,832 | 8.7% | EDGAR |
| SC 13G/A | 2021-02-16 | BAKER BROS. ADVISORS LP | Ascendis Pharma A/S | 3,540,270 | 6.6% | EDGAR |
| SC 13G | 2021-02-16 | BAKER BROS. ADVISORS LP | Adaptimmune Therapeutics PLC | 58,985,262 | 6.4% | EDGAR |
| SC 13G | 2021-02-16 | BAKER BROS. ADVISORS LP | Verastem, Inc. | 10,144,039 | 6.0% | EDGAR |
| SC 13G | 2021-02-16 | BAKER BROS. ADVISORS LP | Altimmune, Inc. | 1,884,451 | 5.1% | EDGAR |
| SC 13G | 2021-02-16 | BAKER BROS. ADVISORS LP | Opthea Ltd | 33,963,240 | 9.8% | EDGAR |
| SC 13G | 2021-02-16 | BAKER BROS. ADVISORS LP | Mereo Biopharma Group plc | 39,631,929 | 11.4% | EDGAR |
| SC 13G | 2021-02-16 | BAKER BROS. ADVISORS LP | Immunocore Holdings plc | 3,352,357 | 7.5% | EDGAR |
| SC 13G | 2021-02-05 | BAKER BROS. ADVISORS LP | Zymeworks Inc. | 4,909,810 | 10.0% | EDGAR |
| SC 13D/A | 2021-01-29 | BAKER BROS. ADVISORS LP | Prelude Therapeutics Inc | 10,126,417 | 28.8% | EDGAR |
| SC 13D/A | 2021-01-29 | BAKER BROS. ADVISORS LP | Zymeworks Inc. | 4,909,810 | 10.0% | EDGAR |
| SC 13D/A | 2021-01-29 | BAKER BROS. ADVISORS LP | IGM Biosciences, Inc. | 3,157,784 | 12.4% | EDGAR |
| SC 13G/A | 2021-01-29 | BAKER BROS. ADVISORS LP | IDERA PHARMACEUTICALS, INC. | 4,608,786 | 12.0% | EDGAR |
| SC 13D/A | 2021-01-05 | BAKER BROS. ADVISORS LP | IGM Biosciences, Inc. | 3,157,271 | 12.4% | EDGAR |
| SC 13D/A | 2020-12-23 | BAKER BROS. ADVISORS LP | Neoleukin Therapeutics, Inc. | 4,227,567 | 10.0% | EDGAR |
| SC 13D/A | 2020-12-11 | BAKER BROS. ADVISORS LP | IGM Biosciences, Inc. | 3,193,022 | 10.0% | EDGAR |
| SC 13D/A | 2020-12-04 | BAKER BROS. ADVISORS LP | BeiGene, Ltd. | 153,853,343 | 13.0% | EDGAR |
| SC 13D/A | 2020-11-24 | BAKER BROS. ADVISORS LP | Kodiak Sciences Inc. | 14,054,698 | 27.6% | EDGAR |
| SC 13D | 2020-09-30 | BAKER BROS. ADVISORS LP | Prelude Therapeutics Inc | 10,121,228 | 31.1% | EDGAR |
| SC 13D/A | 2020-09-08 | BAKER BROS. ADVISORS LP | Kodiak Sciences Inc. | 12,275,749 | 27.3% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.